RIS Rx, LLC

RIS Rx, LLC, based in the US, provides healthcare technology solutions aimed at optimizing operational efficiencies and enhancing patient outcomes for life sciences organizations. Founded in 2020, RIS Rx, LLC develops healthcare technology solutions focused on improving financial decision-making for pharmaceutical manufacturers. The company is headquartered in California City, US, and has completed one deal to date, with Summit Partners investing in June 2025. The founder's history is not publicly detailed.

RIS Rx specializes in healthcare technology solutions designed to enhance operational efficiencies and improve patient outcomes for life sciences organizations. Their core offerings include a proprietary Gross-to-Net Optimization software that enables pharmaceutical manufacturers to make informed financial decisions while ensuring patient well-being remains a priority. This software integrates seamlessly with existing systems used by clients, allowing for comprehensive data management and streamlined program execution. RIS Rx's clientele predominantly includes pharmaceutical manufacturers and healthcare organizations, leveraging their solutions to optimize patient support programs and reduce revenue leakage.

Their products are actively utilized in various geographical markets, specifically in North America and Europe, addressing the unique needs of healthcare systems in these regions. RIS Rx generates revenue through a business-to-business model, primarily via subscription-based services and partnerships with pharmaceutical manufacturers. Clients engage with RIS Rx to access their flagship Gross-to-Net Optimization solution, which provides critical insights and analytics to improve financial performance before expenses are incurred. The company's revenue structure is bolstered by long-term contracts with clients, ensuring a steady stream of income as they continue to adapt and enhance their offerings based on client needs.

This transactional framework allows RIS Rx to deliver tailored healthcare solutions while maintaining a strong financial foundation, essential for ongoing innovation in the healthcare technology space. In June 2025, RIS Rx, LLC secured investment from Summit Partners, which will allow the company to support its innovation and growth initiatives. The investment will enable the development of new products aimed at enhancing their existing software capabilities. Additionally, RIS Rx plans to expand its market presence into new geographic regions, specifically targeting markets in Asia and South America by the end of 2025.